Anthera Pharmaceuticals, Inc. Sets IPO Terms, Will Price in the $13-$15 Per Share Range  
2/3/2010 8:42:26 AM

Bookmark and Share

PEH -- Anthera Pharmaceuticals Inc., a San Mateo, Calif.-based developer of anti-inflammatory drugs, has set its proposed IPO terms to around 4.61 million common shares being offered at between $13 and $15 per share. The company plans to trade on the Nasdaq under ticker symbol ANTH, with Deutsche Bank Securities serving as lead underwriter.